Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 248

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

CD14 dim CD16 + and CD14 + CD16 + Monocytes in Obesity and During Weight Loss: Relationships With Fat Mass and Subclinical Atherosclerosis

Poitou, Christine, Dalmas, Elise, Renovato, Mariana, Benhamo, Vanessa, Hajduch, Froogh, Abdennour, Meriem, Kahn, Jean-François, Veyrie, Nicolas, Rizkalla, Salwa, Fridman, Wolf-Hervé, Sautès-Fridman, Catherine, Clément, Karine, Cremer, Isabelle · 2011 · Arteriosclerosis, Thrombosis, and Vascular Biology

Abstract

Objective—: Studies suggest the implication of CD16 + subpopulations (CD14 + CD16 + , CD14 dim CD16 + ) in inflammatory diseases. We aimed to determine the frequency of these subpopulations during weight loss in obesity and diabetes, conditions associated with changes in systemic inflammation, and we tested the link with subclinical atherosclerosis. Methods and Results—: CD14 dim CD16 + and CD14 + CD16 + frequencies were measured by flow cytometry in lean subjects, obese subjects before and after a hypocaloric diet or gastric surgery, and obese diabetic subjects before and after gastric surgery. Both monocyte subsets were increased in obese subjects, with a significant enrichment of the CD14 dim CD16 + subpopulation in obese diabetic patients. Multivariate analysis demonstrated a link between the percentages of CD14 dim CD16 + monocytes and glycemia, independent of fat mass. Drastic weight loss led to a sharp decrease of this subset, the variations of which were strongly related to fat mass changes. A reduction of at least 5% of fat mass was sufficient to observe a significant decrease of CD14 dim CD16 + monocytes. A diminution of the CD14 + CD16 + subset was also observed during weight loss and was associated with a decrease in intima-media thickness. Conclusion—: This work demonstrates a major impact of fat mass variations on CD14 dim CD16 + monocyte subsets and that the decrease in the CD14 + CD16 + subpopulation is linked to a reduction of subclinical atherosclerosis. Clinical Trial Registration—: URL: http://clinicaltrials.gov . Unique identifier: NCT00476658.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/atvbaha.111.230979

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 248

Metadata

Authors
Poitou, C., Dalmas, E., Renovato, M., Benhamo, V., Hajduch, F., Abdennour, M., Kahn, J.-F., Veyrie, N., Rizkalla, S., Fridman, W.-H., Sautès-Fridman, C., Clément, K., & Cremer, I.
Venue
Arteriosclerosis, Thrombosis, and Vascular Biology
Published
2011-10
Volume
31
Issue
10
Pages
2322-2330
ISSN
  • 1079-5642 (ISSN-L)
  • 1524-4636
OpenAlex
W2145979546
Cited by
248
References
5
FWCI
10.16
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: CD14 dim CD16 + and CD14 + CD16 + Monocytes in Obesity and During Weight Loss: Relationships With Fat Mass and Subclinical Atherosclerosis. https://app.cochat.ai/papers/10.1161/atvbaha.111.230979
The paper
Poitou, C., Dalmas, E., Renovato, M., Benhamo, V., Hajduch, F., Abdennour, M., Kahn, J.-F., Veyrie, N., Rizkalla, S., Fridman, W.-H., Sautès-Fridman, C., Clément, K., & Cremer, I. (2011). CD14 dim CD16 + and CD14 + CD16 + Monocytes in Obesity and During Weight Loss: Relationships With Fat Mass and Subclinical Atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology. https://doi.org/10.1161/atvbaha.111.230979

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.